Tag: NGS based RNA sequencing market forecast

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The NGS-Based RNA-Sequencing Market Size Shifted, And What Is the Outlook Through 2034?#_x000D_

The market for ngs-based rna-sequencing has seen a significant escalation in the past few years. Its expansion is projected to rise from $3.41 billion in 2024 to a hefty $4.2 billion in 2025, implying a compound annual growth rate (CAGR) of 23.3%. The remarkable development during this historical period is credited to initiatives in genomic research, a lower cost of sequencing, drug invention and enhancement, individualized medicine, and a surge in ngs adoption._x000D_

_x000D_

Over the coming years, the market for ngs-based rna-sequencing is projected to experience significant expansion. It is anticipated to surge to a value of $10.26 billion in 2029, with a compound annual growth rate (CAGR) of 25.0%. This projected growth within the forecast period can be credited to factors such as clinical diagnostics, worldwide collaborations, ethical and regulatory frameworks, as well as agricultural and environmental research, and green genomics. The main trends within this period are expected to include single-cell rna-sequencing (scrna-seq), spatial transcriptomics, epitranscriptomics, the integration of multi-omics, and the rise of sustainable agriculture._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp_x000D_

_x000D_

#What are the Fundamental Drivers and Innovations Shaping the NGS-Based RNA-Sequencing Market?#_x000D_

The surge in precision medicine is fueling the expansion of the NGS-based RNA sequencing market. This form of medicine enables doctors to create customised treatment strategies and make medicinal decisions based on an understanding of the patient’s genetic disease. Precision treatments for serious illnesses like cancer are on the rise. NGS-based RNA sequencing aids in pinpointing the exact cause of an ailment and prescribing relevant precision medicine. For example, a report from the Personalized Medicine Coalition (PMC), a nonprofit organization in the US, noted in February 2023 that personalized medicines made up 35% of newly approved NMEs in 2021. Twelve new approvals in 2022 ensured that they constituted at least a quarter of new drug approvals for the past eight years, a significant jump from less than 10% a decade ago. The rising demand for precision medicines will invariably boost the need for NGS-based RNA sequencing._x000D_

_x000D_

#How Is the NGS-Based RNA-Sequencing Market Segmented?#_x000D_

The ngs-based rna-sequencingmarket covered in this report is segmented – _x000D_

_x000D_

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management_x000D_

2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing_x000D_

3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics_x000D_

4) By End User: Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents_x000D_

2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables_x000D_

3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services_x000D_

4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=7416&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the NGS-Based RNA-Sequencing Market Growth?#_x000D_

North America was the largest region in the NGS-based RNA sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#What Key Trends Are Shaping the Future of the NGS-Based RNA-Sequencing Market?#_x000D_

One of the main trends in the NGS-based RNA sequencing market is the formation of strategic partnerships. This occurs when companies team up with NGS-based RNA sequencing businesses in order to enter new markets and make the most of each other’s resources. For example, in May 2022, the Biomedical Advanced Research and Development Authority (BARDA), a branch of the U.S. Department of Health and Human Services, joined forces with several industrial and academic partners. This collaboration’s goal is to enhance the ability to promptly react to public health emergencies and establish a new diagnostic capacity able to handle all known and newly-emerging respiratory RNA viruses in one single test._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report_x000D_

_x000D_

#How Is the NGS-Based RNA-Sequencing Market Defined and What Are Its Core Parameters?#_x000D_

NGS-based RNA-sequencing is used to identify and measure the amount of ribonucleic acid (RNA) present in a biological sample at a certain moment, using next-generation sequencing (NGS). The massively parallel sequencing technology known as “”next-generation sequencing”” (NGS) provides extremely high throughput, scalability, and speed. This approach can ascertain the nucleotide sequence of whole genomes or specific DNA or RNA portions._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7416_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the NGS-Based RNA-Sequencing Market?

The market size for NGS-based RNA-sequencing has experienced substantial growth recently. It is expected to expand from $3.41 billion in 2024 to $4.23 billion in 2025, indicating a compound annual growth rate (CAGR) of 24.2%. The impressive growth during the historical period is due to factors such as genomic research initiatives, a decrease in sequencing expenses, advancements in drug discovery and development, personalized medicine, and the rising adoption of NGS.

What Growth Rate Is Forecasted for the NGS-Based RNA-Sequencing Market by 2029?

The market size for NGS-based RNA-sequencing is predicted to experience significant expansion in the coming years. It is projected to reach a value of $10.4 billion in 2029, with a compound annual growth rate (CAGR) of 25.2%. The anticipated growth during this forecast period can be linked to factors such as clinical diagnostics, international collaborations, ethical and regulatory structures, research in agriculture and environment, and green genomics. Key trends anticipated during this forecast period are single-cell rna-sequencing (scrna-seq), spatial transcriptomics, epitranscriptomics, multi-omics integration, and sustainable agriculture.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp

Which Key Companies Are Shaping the Future of the NGS-Based RNA-Sequencing Market?

Major companies operating in the ngs-based rna-sequencing market include Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hamilton Company, Takara Bio Inc., Tecan Trading AG, GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Becton, Dickinson and Company, Genohub LLC, BaseClear B.V., Genewave SAS, Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

Which Factors Are Driving Demand in the NGS-Based RNA-Sequencing Industry?

The NGS-based RNA sequencing market is experiencing growth due to the rise in precision medicine. This type of medicine utilizes genetic information about a patient’s disease to guide doctors in crafting personalized treatment plans and making care decisions. There has been a surge in developing precision medicines to treat serious illnesses like cancer. NGS-based RNA sequencing plays a crucial role in divulging the fundamental cause of disease and recommending specific precision medicine for therapy. As an example, a report by the US-based charity Personalized Medicine Coalition (PMC) in February 2023 showed that personalized medicines represented 35% of all newly approved NMEs in 2021. Despite 12 new approvals in 2022, they have consistently constituted at least a quarter of all new drug approvals for the last eight years, a substantial leap from less than 10% ten years back. As precision medicine becomes more in demand, then NGS-based RNA sequencing demand will also rise.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7416&type=smp

How Is the NGS-Based RNA-Sequencing Market Segmented by Several Divisions?

The ngs-based rna-sequencing market covered in this report is segmented –

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management

2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing

3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics

4) By End User: Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users

Subsegments:

1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents

2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables

3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services

4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms

What are the Emerging Market Trends Driving the Growth of the NGS-Based RNA-Sequencing Industry?

The NGS-based RNA sequencing market is noting a significant trend of Strategic Partnership. Companies are forming alliances with NGS-based RNA sequencing firms to not only break into new markets but also make the most of one another’s resources. For example, in May 2022, the Biomedical Advanced Research and Development Authority (BARDA), a part of the U.S. Department of Health and Human Services, entered into collaboration with various industry and academic collaborators. The purpose of this collaboration is to boost the ability to promptly respond to public health crises and construct an innovative diagnostic tool that can detect all known and upcoming respiratory RNA viruses in one singular test.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Which Regions Are Driving Growth in the NGS-Based RNA-Sequencing Market?

North America was the largest region in the NGS-based RNA sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7416

This Report Delivers Insight On:

1. How big is the ngs-based rna-sequencing market, and how is it changing globally?

2. Who are the major companies in the ngs-based rna-sequencing market, and how are they performing?

3. What are the key opportunities and risks in the ngs-based rna-sequencing market right now?

4. Which products or customer segments are growing the most in the ngs-based rna-sequencing market?

5. What factors are helping or slowing down the growth of the ngs-based rna-sequencing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2323 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of theNGS-Based RNA-Sequencing Market from 2025 to 2034?

The growth of precision medicine is contributing to the expansion of the NGS-based RNA sequencing market. Precision medicine tailors treatment based on genetic insights into a patient’s disease, offering effective solutions for conditions like cancer. NGS-based RNA sequencing helps identify the genetic causes of diseases, enabling the use of precision medicine. For example, the Personalized Medicine Coalition reported that personalized medicines accounted for 35% of newly approved NMEs in 2021. As the demand for precision medicine rises, the demand for NGS-based RNA sequencing is expected to grow.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp

#How Does the ProjectedNGS-Based RNA-Sequencing Market Growth Compare Over the Forecast Period?

The NGS-based RNA-sequencing market has grown exponentially in recent years. It is expected to grow from $3.41 billion in 2024 to $4.23 billion in 2025, with a compound annual growth rate (CAGR) of 24.2%. The growth is due to genomic research initiatives, reductions in sequencing costs, drug discovery and development, personalized medicine, and the increasing adoption of NGS technologies.

The NGS-based RNA-sequencing market is expected to see exponential growth, reaching $10.4 billion by 2029 at a CAGR of 25.2%. Growth is driven by clinical diagnostics, global collaborations, regulatory frameworks, agricultural and environmental research, and green genomics. Major trends include single-cell RNA-sequencing (scRNA-seq), spatial transcriptomics, epitranscriptomics, multi-omics integration, and sustainable agriculture practices.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7416

How Are Market Trends and Innovations Revolutionizing theNGS-Based RNA-Sequencing Industry in Recent Times?

Strategic partnerships are becoming a key trend in the NGS-based RNA sequencing market. Companies are forming alliances to enter new markets and leverage each other’s strengths. For instance, in May 2022, the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services, partnered with several industry and academic entities. This collaboration aims to enhance the ability to quickly respond to public health crises and develop a diagnostic tool to detect a wide range of respiratory RNA viruses in a single test.

Which Key Market Players Are Shaping the Future and Growth of theNGS-Based RNA-Sequencing Market?

Major companies operating in the ngs-based rna-sequencing market include Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hamilton Company, Takara Bio Inc., Tecan Trading AG, GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Becton, Dickinson and Company, Genohub LLC, BaseClear B.V., Genewave SAS, Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

What Are the Core Segments of the NGS-Based RNA-Sequencing Market, and How Do They Contribute to Growth?

The ngs-based rna-sequencing market covered in this report is segmented –

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management

2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing

3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics

4) By End User: Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users

Subsegments:

1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents

2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables

3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services

4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=7416&type=smp

What Regions Are Dominating the NGS-Based RNA-Sequencing Market Growth?

North America was the largest region in the NGS-based RNA sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Gobal NGS-Based RNA-Sequencing Maret 2025, By The Business Research Company:

Antisense & RNAi Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report

Biosimilar Hormones Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report

Microbiology Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the ngs-based rna-sequencing market?

In the recent past, there has been a substantial growth in the market size of NGS-based RNA-sequencing. The market, which was valued at $3.41 billion in 2024, is predicted to surge to a value of $4.23 billion in 2025, representing a compound annual growth rate (CAGR) of 24.2%. Various factors have contributed to the growth witnessed in the historic period, including initiatives in genomic research, a decrease in sequencing costs, drug discovery and development, the proliferation of personalized medicine, and the increased acceptance of NGS.

What will be the ngs-based rna-sequencing market size in the future?

Over the next few years, the market size for NGS-based RNA-sequencing is anticipated to experience a significant upsurge. It is projected to reach $10.4 billion in 2029, with an annual compound growth rate (CAGR) of 25.2%. This growth throughout the forecast period is mainly due to clinical diagnostics, global collaborations, ethical and regulatory frameworks, and research in agriculture and environment, along with green genomics. Single-cell RNA-sequencing (scrna-seq), spatial transcriptomics, epitranscriptomics, multi-omics integration, and sustainable agriculture are the main trends expected during this forecast period.

Get your ngs-based rna-sequencing market report here!

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

What main drivers are fueling expansion in the ngs-based rna-sequencing market?

The NGS-based RNA sequencing market is expanding on the back of advancements in precision medicine. By providing doctors with the capacity to create patient-specific treatment plans grounded in genetic understanding of diseases, precision medicine is transforming healthcare, particularly concerning serious illnesses like cancer. The role of NGS-based RNA sequencing is crucial here as it identifies the fundamental cause of the disease, thus paving the way for suitably customized precision medicine. As corroborated by a report from the Personalized Medicine Coalition (PMC), a nonprofit organization based in the U.S., personalized medicines made up 35% of the newly approved NMEs in 2021. Further enhancing their presence with 12 new approvals in 2022, they continually represented at least 25% of new drug endorsements over the last eight years. This is a noteworthy leap from less than 10% a decade earlier. Correspondingly, as the popularity of precision medicines surges, so will the need for NGS-based RNA sequencing.

What key areas define the segmentation of the global ngs-based rna-sequencing market?

The ngs-based rna-sequencing market covered in this report is segmented –

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management

2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing

3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics

4) By End User: Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users

Subsegments:

1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents

2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables

3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services

4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp

Who are the dominant players expanding their reach in the ngs-based rna-sequencing market?

Major companies operating in the ngs-based rna-sequencing market include Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hamilton Company, Takara Bio Inc., Tecan Trading AG, GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Becton, Dickinson and Company, Genohub LLC, BaseClear B.V., Genewave SAS, Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.

How are evolving market trends shaping ngs-based rna-sequencing Strategies?

The trend of Strategic Partnership holds significant sway in the NGS-based RNA sequencing market. To penetrate into new markets and employ each other’s resources to their advantage, companies are forming alliances with NGS-based RNA sequencing firms. For instance, in May 2022, The Biomedical Advanced Research and Development Authority (BARDA), which comes under the aegis of the U.S. Department of Health and Human Services, forged synergies with numerous industry and academic associates. The prime goal of this collaboration is to strengthen the ability to quickly tackle public health crises and formulate a unique diagnostic method that accommodates all known and emerging respiratory RNA viruses with a single test.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7416

Which regions are emerging as leaders in the ngs-based rna-sequencing market?

North America was the largest region in the NGS-based RNA sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Antisense & RNAi Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report

Biosimilar Hormones Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report

Microbiology Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Long-Term Projected Growth Rate for the NGS-Based RNA-Sequencing Market, and What Are the Key Drivers?

In recent times, there has been a tremendous growth in the market size of NGS-based RNA-sequencing. It is predicted to expand from its current value of $3.41 billion in 2024 to an estimated $4.23 billion in 2025, marking a compound annual growth rate (CAGR) of 24.2%. The observed growth in the historical period is mainly due to factors such as genomic research initiatives, a decrease in sequencing pricing, advancements in drug discovery and development, the rise of personalized medicine, and a surge in the adoption of ngs.

Over the upcoming years, the market size of NGS-based RNA-sequencing is set to experience an explosive increase, reaching up to $10.4 billion in 2029 with a compound annual growth rate (CAGR) of 25.2%. Various factors such as clinical diagnostics, international collaborations, ethical and regulatory guidelines, and research in agriculture and environment, as well as green genomics, are attributions to this expected growth within the forecast period. Notable trends within this time frame encompass single-cell rna-sequencing (scrna-seq), spatial transcriptomics, epitranscriptomics, integration of multi-omics, and sustainable farming.

Which Factors Are Enhancing the Growth of the ngs-based rna-sequencing Market?

The NGS-based RNA sequencing market is being propelled by the rise in precision medicine. This form of medicine facilitates doctors in creating bespoke treatment plans and making clinical decisions grounded in genetic insights of a patient’s illness. There is an escalation in the use of precision medicines in dealing with critical illnesses like cancer. NGS-based RNA sequencing plays a crucial role in pinpointing the origins of the disease, allowing doctors to prescribe the right precision medicine for treatment purposes. For instance, a report issued by the U.S. nonprofit organization, Personalized Medicine Coalition (PMC), in February 2023, revealed that personalized medicines constituted 35% of the fresh NMEs approved in 2021. Even with 12 new approvals in 2022, they have consistently held a share of at least a quarter of all new drug approvals for the past eight years, indicating a notable jump from less than 10% ten years ago. As precision medicine demand grows, so will the demand for NGS-based RNA sequencing.

Explore Comprehensive Insights Into The Global NGS-Based RNA-Sequencing Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7416&type=smp

Which Companies Are Leading the Charge in Expanding the NGS-Based RNA-Sequencing Market?

Major companies operating in the ngs-based rna-sequencing market include:

• Illumina Inc._x000D_

• Thermo Fisher Scientific Inc._x000D_

• Oxford Nanopore Technologies Ltd._x000D_

• Agilent Technologies Inc._x000D_

• BGI Group_x000D_

What New Trends Are Reshaping the NGS-Based RNA-Sequencing Market and Its Opportunities?

The tendency towards strategic alliances is a major tendency in the NGS-based RNA sequencing market. To break into new markets and make use of each other’s resources, corporations are forming collaborations with NGS-based RNA sequencing businesses. For example, in May 2022, The Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services, initiated collaborations with various industry and academic partners. The aim of the alliance is to enhance rapid response capability in public health emergencies and to cultivate a new diagnostic method that can detect all known and emerging respiratory RNA viruses in one single test.

Secure Your Global NGS-Based RNA-Sequencing Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

How Are the Key Segments of the NGS-Based RNA-Sequencing Market Impacting Its Expansion and Revenue Streams?

The ngs-based rna-sequencing market covered in this report is segmented –

1) By Product And Service: Sample Preparation Products, Sequencing Platforms and Consumables, Sequencing Services, Data Analysis, Storage, and Management

2) By Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing

3) By Application: Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics

4) By End User: Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users

Subsegments:

1) By Sample Preparation Products: RNA Extraction Kits, Library Preparation Kits, Reverse Transcription Kits, Quality Control Reagents

2) By Sequencing Platforms And Consumables: Sequencing Instruments, Sequencing Consumables

3) By Sequencing Services: Contract Sequencing Services, Custom Library Preparation Services, Consultation And Experimental Design Services

4) By Data Analysis, Storage, And Management: Bioinformatics Software, Data Analysis Services, Cloud-Based Data Storage Solutions, Data Management Platforms

What Are the Top Regions Fueling Growth in the NGS-Based RNA-Sequencing Market?

North America was the largest region in the NGS-based RNA sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

How Is the NGS-Based RNA-Sequencing Market Defined Across Different Regions?

NGS-based RNA-sequencing is used to identify and measure the amount of ribonucleic acid (RNA) present in a biological sample at a certain moment, using next-generation sequencing (NGS). The massively parallel sequencing technology known as ”next-generation sequencing” (NGS) provides extremely high throughput, scalability, and speed. This approach can ascertain the nucleotide sequence of whole genomes or specific DNA or RNA portions.

Browse Through More Similar Reports By The Business Research Company:

Antisense & RNAi Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report

Biosimilar Hormones Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report

Microbiology Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/microbiology-diagnostic-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: